{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-011286","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.166768+00:00","generated_at":"2026-05-21T03:36:33.198433+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Dermata Therapeutics faces Nasdaq delisting for minimum bid price; plans hearing","bullets":["Regained compliance with Nasdaq stockholders' equity requirement on May 14, 2025.","Received notice of non-compliance with $1.00 minimum bid price; securities subject to delisting.","Reverse stock split within past year triggers accelerated delisting; suspension possible May 23, 2025.","Company plans to request hearing by May 21, 2025 to stay suspension pending panel decision.","No assurance compliance plan will be accepted; delisting risk remains if plan fails."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-011286","json":"https://secwatch.observer/filing/0001641172-25-011286.json","markdown":"https://secwatch.observer/filing/0001641172-25-011286.md","text":"https://secwatch.observer/filing/0001641172-25-011286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225011286/0001641172-25-011286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225011286/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:36:33.198433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}